TEMIXYS is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Celltrion Usa, Inc.. The primary component is Lamivudine; Tenofovir Disoproxil Fumarate.
Product ID | 72606-002_0732cedf-911f-4b66-b610-3790d1df6b9e |
NDC | 72606-002 |
Product Type | Human Prescription Drug |
Proprietary Name | TEMIXYS |
Generic Name | Lamivudine And Tenofovir Disoproxil Fumarate |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2018-11-16 |
Marketing Category | NDA / NDA |
Application Number | NDA211284 |
Labeler Name | CELLTRION USA, INC. |
Substance Name | LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE |
Active Ingredient Strength | 300 mg/1; mg/1 |
Pharm Classes | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2019-11-07 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA211284 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2019-11-07 |
Ingredient | Strength |
---|---|
LAMIVUDINE | 300 mg/1 |
NDC | Brand Name | Generic Name |
---|---|---|
32228-004 | TEMIXYS | lamivudine and tenofovir disoproxil fumarate |
72606-002 | TEMIXYS | lamivudine and tenofovir disoproxil fumarate |
49502-450 | CIMDUO | Lamivudine and Tenofovir Disoproxil Fumarate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
TEMIXYS 79229584 5652077 Live/Registered |
CELLTRION, INC. 2018-02-01 |